🚀 ICE is transforming cardiac interventions! @DonalErwan & @AugustinCoisne highlight the shift from procedural guidance to precision intervention. 🔹 Real-time 3D/4D imaging 🔹 Safer, smarter workflows 🔹 AI-assisted navigation ☑️doi.org/10.1093/ehjci/jeag21… @EHJCVIEiC

🚨 Can AI decode TR prognosis—or merely encode measurement errors? @lpbadano & Penso challenge PISA-derived EROA, Doppler-estimated pressures & missing quantitative RV assessment. AI 🤖 cannot correct flawed measurements! ☑️doi.org/10.1093/ehjci/jeag19… @EHJCVIEiC @EACVIPresident

🚨 Featured on the cover of EHJ–Cardiovascular Imaging! 9,761 patients with TR: Explainable AI reveals key mortality predictors. 🔹 SPAP & right atrial pressure dominate 🔹 EROA outperforms integrated TR grading 🔗 doi.org/10.1093/ehjci/jeag16… @EHJCVIEiC @EACVIPresident

🫀🚀 Ready to take your 3D Echo skills to another dimension? 👽 Join international experts in Berlin, 22–24 Jan 2027! Hands-on training, advanced imaging & real cases by @NMerke & #friends ⚠️ Only a few places left! 🔗 dhzb-akademie.de/course/3d-w…

🗳️ EACVI Board Elections 2026! Proud to support @LunaGargani & @papadocardio for the EACVI Echo Council! Two outstanding experts with vision, dedication and passion for cardiovascular imaging. #echofirst They have my vote! ❤️ #EACVI #EACVIElections2026 #Echo

Libman-Sacks endocarditis with SLE stage III lupus nephritis youtu.be/ZCwboqMrwYI?si=uRI1… via @YouTube

marantic endocarditis vs. infective endocarditis youtu.be/kyrrC1tzIz0?si=jrOq… via @YouTube

Libman-Sacks Endocarditis and Embolic Cerebrovascular Disease youtu.be/P9qiaJREuTQ?si=S1jb… via @YouTube

🫀 Ready to go beyond 2D? Join the 3D Advanced Echocardiography Workshop in Berlin: expert faculty, hands-on training with real 3D datasets, valve imaging, RV analysis & practical tips for daily practice. By @NMerke @dhzcharite 👉 dhzb-akademie.de/course/3d-w… #3DEcho #Echofirst

🫀 Stress CMR delivers powerful long-term risk stratification in hypertension without known CAD. In 2,019 patients, ischaemia predicted MACE >3-fold over 6.7 years (39% vs 12%; HR 4.1). Unrecognized MI: HR 3.6. Why stop at conventional risk factors ❓ ✅doi.org/10.1093/ehjci/jeag16…